Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/237353 
Year of Publication: 
2019
Series/Report no.: 
ETLA Working Papers No. 68
Publisher: 
The Research Institute of the Finnish Economy (ETLA), Helsinki
Abstract: 
Venture Capital (VC) funding raised by companies producing Artificial Intelligence (AI) solutions is on the rise. In healthcare, VC funding is distributed unevenly and certain technologies have attracted significantly more funding than others. The funding decisions made by VC companies also work as a technology driver for the industry. We analyzed a database of 106 Healthcare AI companies collected from open online sources to understand factors affecting VC funding of AI companies operating in different areas of healthcare. Companies acting as R&D catalysts have been most succesful in raising VC funding. The results suggest that there is a significant connection between higher funding and having research organizations and pharmaceutical companies as the customer of the product or service. In addition, focusing on AI solutions that are applied to direct patient care delivery is associated with lower funding. We discuss the implications of our findings on health technology research and development, and on the barriers of platform data markets in healthcare industry.
Subjects: 
Artificial Intelligence
Capital Funding
Technology
JEL: 
G2
G24
I1
I19
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.